Patients ( N = 825 ) with type 2 diabetes and hypertension ( mean seated systolic blood pressure [ SBP ] 130-159 mmHg and diastolic blood pressure [ DBP ] 80-99 mmHg ) were randomized ( double blind ) to 10 mg or 25 mg empagliflozin or placebo once daily for 12 weeks .